[go: up one dir, main page]

ES8303287A1 - Un procedimiento para preparar compuestos de aminoetanol. - Google Patents

Un procedimiento para preparar compuestos de aminoetanol.

Info

Publication number
ES8303287A1
ES8303287A1 ES509537A ES509537A ES8303287A1 ES 8303287 A1 ES8303287 A1 ES 8303287A1 ES 509537 A ES509537 A ES 509537A ES 509537 A ES509537 A ES 509537A ES 8303287 A1 ES8303287 A1 ES 8303287A1
Authority
ES
Spain
Prior art keywords
formula
compounds
procedure
reaction
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES509537A
Other languages
English (en)
Other versions
ES509537A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kowa Co Ltd
Original Assignee
Kowa Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kowa Co Ltd filed Critical Kowa Co Ltd
Publication of ES8303287A1 publication Critical patent/ES8303287A1/es
Publication of ES509537A0 publication Critical patent/ES509537A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C203/00—Esters of nitric or nitrous acid
    • C07C203/02—Esters of nitric acid
    • C07C203/04—Esters of nitric acid having nitrate groups bound to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/69—Two or more oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
    • C07D303/26—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds having one or more free hydroxyl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE COMPUESTOS AMINOETANOL Y DE SUS SALES DE ADICION DE ACIDO, DE FORMULA (I), EN LA QUE A ES UN ENLACE DIRECTO O EL ENLACE -O-CH -; B ES EL GRUPO ALCOHILENO C <- UNIDO A UN ATOMO DEL ANILLO D, DIRECTAMENTE O A TRAVES DE UN HETEROATOMO; W ES CARBONO O NITROGENO; R Y R PUEDEN SER VARIOS RADICALES; M VALE 1 O 2; Y N VALE 1-3. CONSISTE EN LA REACCION DE UN COMPUESTO DE FORMULA (II), EN LA QUE TODOS LOS SIMBOLOS TIENEN EL MISMO SIGNIFICADO QUE EN LA FORMULA (I), CON ACIDO NITRICO FUMANTE, A MEZCLAS DE NITRICO Y ANHIDRIDO ACETICO O ACIDO NITRICO Y ACIDO SULFURICO, PARA FORMAR EL ESTER NITRATO CORRESPONDIENTE. LA REACCION SE LLEVA A CABO EN AUSENCIA O PRESENCIA DE DISOLVENTE, A UNA TEMPERATURA PROXIMA A -40 C. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS PARA EL TRATAMIENTO DE ENFERMEDADES DEL SISTEMA CARDIOVASCULAR.
ES509537A 1980-02-13 1982-02-12 Un procedimiento para preparar compuestos de aminoetanol. Granted ES509537A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1543380A JPS56113748A (en) 1980-02-13 1980-02-13 Aminoethanol derivative and its preparation

Publications (2)

Publication Number Publication Date
ES8303287A1 true ES8303287A1 (es) 1983-02-01
ES509537A0 ES509537A0 (es) 1983-02-01

Family

ID=11888654

Family Applications (2)

Application Number Title Priority Date Filing Date
ES499354A Expired ES8300677A1 (es) 1980-02-13 1981-02-12 Un procedimiento para preparar compuestos de aminoetanol
ES509537A Granted ES509537A0 (es) 1980-02-13 1982-02-12 Un procedimiento para preparar compuestos de aminoetanol.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES499354A Expired ES8300677A1 (es) 1980-02-13 1981-02-12 Un procedimiento para preparar compuestos de aminoetanol

Country Status (11)

Country Link
US (2) US4374840A (es)
EP (1) EP0034461B1 (es)
JP (1) JPS56113748A (es)
AT (1) ATE3543T1 (es)
AU (1) AU6698681A (es)
CA (1) CA1157474A (es)
DE (1) DE3160335D1 (es)
DK (1) DK60981A (es)
ES (2) ES8300677A1 (es)
IE (1) IE810221L (es)
ZA (1) ZA81932B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58109461A (ja) * 1981-12-24 1983-06-29 Kowa Co 新規ベンズアミド誘導体
JPS5965076A (ja) * 1982-10-05 1984-04-13 Kowa Co 新規なキノリン誘導体
IE56324B1 (en) * 1982-12-13 1991-06-19 American Home Prod Phenethylamine derivatives and intermediates therefor
JPS6025958A (ja) * 1983-07-21 1985-02-08 Kowa Co 新規アミノアルキル置換ベンゼン誘導体
DE3443998A1 (de) * 1984-12-01 1986-06-05 Boehringer Mannheim Gmbh, 6800 Mannheim Amino-propanol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte
DE3512627A1 (de) * 1985-04-06 1986-10-09 Boehringer Mannheim Gmbh, 6800 Mannheim Amino-propanol-derivate, verfahren zu deren herstellung, verwendung derselben und diese enthaltende arzneimittel
NL8802276A (nl) * 1988-09-15 1990-04-02 Cedona Pharm Bv Geneesmiddel met relaxerende werking, dat als aktieve stof een nitraatester bevat.
ES2065291B1 (es) * 1993-07-30 1995-10-01 Prodesfarma Sa "nitrato esteres de 1-ariloxi-3-alquilamino-2-propanoles, utilizacion y composicion farmaceutica correspondiente"
JPH09507672A (ja) * 1994-01-19 1997-08-05 ビイク ネダーラント ベスローテン フェンノートシャップ ニトロキシ基含有ベンジルアミン誘導体及び循環器疾患並びに眼内圧増加の治療のためのその使用
US5541204A (en) * 1994-12-02 1996-07-30 Bristol-Myers Squibb Company Aryloxypropanolamine β 3 adrenergic agonists
US6310052B1 (en) 1996-06-04 2001-10-30 Queen's University At Kingston Nitrate esters and their use for neurological conditions
IT1303671B1 (it) * 1998-07-28 2001-02-23 Nicox Sa Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
EP3827747A1 (en) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
KR20090071598A (ko) 2006-09-18 2009-07-01 랩터 파마슈티컬 인코포레이티드 수용체 결합 단백질(ｒａｐ)-접합체 투여에 의한 간 질환의 치료
ES2728225T3 (es) 2009-02-20 2019-10-23 2 Bbb Medicines B V Sistema de administración de fármacos a base de glutatión
KR20190116576A (ko) 2009-05-06 2019-10-14 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1485919A (en) * 1975-08-12 1977-09-14 Grindstedvaerket As Pyridine derivatives
DE2805404A1 (de) * 1978-02-09 1979-08-16 Merck Patent Gmbh 1-aryloxy-3-nitratoalkylamino-2-propanole und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
DK60981A (da) 1981-08-14
EP0034461A1 (en) 1981-08-26
US4374840A (en) 1983-02-22
ATE3543T1 (de) 1983-06-15
ES499354A0 (es) 1982-11-01
JPS56113748A (en) 1981-09-07
ES8300677A1 (es) 1982-11-01
EP0034461B1 (en) 1983-05-25
CA1157474A (en) 1983-11-22
ES509537A0 (es) 1983-02-01
IE810221L (en) 1981-08-13
US4482562A (en) 1984-11-13
DE3160335D1 (en) 1983-07-07
ZA81932B (en) 1982-03-31
JPS6130652B2 (es) 1986-07-15
AU6698681A (en) 1981-08-20

Similar Documents

Publication Publication Date Title
ES8303287A1 (es) Un procedimiento para preparar compuestos de aminoetanol.
ES8303383A1 (es) Un procedimiento para la preparacion de derivados del 1,2,5-tiadiazol
ES8706672A1 (es) Un procedimiento para la preparacion de pirazolo y piridazo-pirazolinas, piridazinas y diazepinas.
ES8507480A1 (es) Un metodo para producir un derivado de amina
ES8301966A1 (es) Procedimiento para preparar derivados de pirimidona
ES8801618A1 (es) Un procedimiento para preparar derivados de arilciclobutilalquilamina
MX173360B (es) Procedimiento para la produccion de fenil-4,5,6,7-tetrahidro-2h-isoindol-1,3-dionas 2-substituidas
ES8403453A1 (es) Un procedimiento para preparar amidas del acido 1-metil-5-p-toluoilpirrol-2-acetico.
ES8603497A1 (es) Procedimiento para preparar derivados de cefalosporina
ES8300692A1 (es) Un procedimiento para la preparacion de derivados de acido carbamico
ES8301990A1 (es) Un procedimiento para la preparacion de acidos 1, carbadestiapen-2-em-3-carboxililos 2- y 6- sustituidos.
ES8607243A1 (es) Esteres de aminoacidos y de peptidos cromogenos
ES8706654A1 (es) Un procedimiento para la preparacion de nuevos derivados de benzotiazina
ES8305345A1 (es) &#34;procedimiento para la preparacion de nuevos derivados de acidos 2-amino-carboxilicos&#34;.
ES8305755A1 (es) Procedimiento para preparar derivados de pirimidona.
ES8300711A1 (es) Un procedimiento para la preparacion de un derivado cis-4,5-disustituidos de imidazolidin-2-ona opticamente activo.
ES8301883A1 (es) Procedimiento para la preparacion de derivados de ciclohexe-no
ES8600730A1 (es) Procedimiento para la preparacion de agentes anti-psoriaticos del tipo naftalenico
ES8603400A1 (es) Derivados de prostaglandina
ES8609246A1 (es) Un procedimiento para preparar un derivado de 3-carbonil-1- aminoalquil-1h-indol
ES8607960A1 (es) Procedimiento para preparar acidos aroil-benzofuran y benzo-tiofen-aceticos y-propionicos
ES8800193A1 (es) Procedimiento para preparar 2,4-difenil-1,3-dioxanos
ES8606348A1 (es) Un metodo para preparar un derivado de 9-bencilpurina
ES8604162A1 (es) Procedimiento para preparar nuevos bencimidazoles
ES8201954A1 (es) Un metodo para la preparacion de derivados del acido prope- noico.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20000601